In summary, this work may form the basis for future investigations studying the impact of abrogation of IL‐1β signalling on PPARγ and its effects on normalization of barrier homeostasis in common inflammatory skin disorders such as atopic dermatitis and psoriasis. This evidence concerns the gene PPARG and inflammatory skin disease.